Devices and methods for target molecule characterization
US-9395352-B2 · Jul 19, 2016 · US
US10139417B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10139417-B2 |
| Application number | US-201314376154-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 31, 2013 |
| Priority date | Feb 1, 2012 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments of the present disclosure relate to amino acid, modified amino acid, peptide and protein identification and sequencing, by means of, for example, electronic detection of individual amino acids or small peptides.
Opening claim text (preview).
What is claimed is: 1. An apparatus for sequencing a molecule comprising: at least a first and a second electrode; a dielectric layer of between about 1 nm and about 4 nm separating the first and second electrodes; a membrane between about 10 to about 100 nm in thickness; a channel containing an electrolyte solution, wherein the membrane spans and divides the channel to form a cis chamber and a trans chamber, wherein the cis chamber and the trans chamber are in fluid communication with one another via a nanopore, and a bead in the cis chamber and arranged within 150 μm of the nanopore, the bead including a molecule for sequencing and/or identifying bound thereto, wherein: the nanopore is formed on the same substrate as the pair of electrodes, the nanopore is between about 1 nm and about 5 nm in diameter at the point where it passes through the electrodes, and the electrodes include between about 1 nm to about 5 nm of silver, gold, palladium and/or platinum, and the electrodes are functionalized. 2. The apparatus according to claim 1 , wherein each chamber is filled with an electrolyte comprising at least one of KCl and NaClO3 in a concentration between about 1 mM to about 1M. 3. The apparatus according to claim 1 , wherein the bead includes enzymes attached thereto which are fixed in turn to the walls of the channel. 4. The apparatus according to claim 3 , wherein the enzymes comprise proteases selected from the group consisting of trypsin, chymotrypsin, pepsin, papain, elastase and combinations thereof. 5. The apparatus according to claim 3 , wherein the bead is functionalized with proteosomes to sequentially degrade proteins into their component amino acids. 6. The apparatus according to claim 3 , wherein the molecule comprises an isolated protein or peptide. 7. The apparatus according to claim 1 , further comprising one or more reference electrodes. 8. The apparatus according to claim 1 , wherein the bead is affixed to the wall of the channel. 9. The apparatus according to claim 1 , wherein the molecule is not a protease.
involving C-terminal degradation · CPC title
Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.